Position in GRAL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,348,537
+$325,118 QoQ
Shares Held
19,753
-0.3% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#101
of 371 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Perigon Wealth Management, LLC holds $22,174,741 across 15 Diagnostics & Research names. GRAL ranks #2 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
26,698 | $13,385,309 | |
| 2 | GRAL |
GRAIL, Inc.
This page
|
19,753 | $1,348,537 | |
| 3 | GH |
Guardant Health, Inc.
|
7,149 | $1,072,564 | |
| 4 | ILMN |
Illumina, Inc.
|
5,708 | $1,003,637 | |
| 5 | DHR |
Danaher Corp /De/
|
5,081 | $967,828 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,651 | $869,152 | |
| 7 | A |
Agilent Technologies, Inc.
|
4,746 | $630,411 | |
| 8 | NTRA |
Natera, Inc.
|
2,293 | $622,434 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,348,537 | 19,753 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,023,419 | 19,803 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,664,725 | 19,450 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,142,214 | 19,317 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $911,933 | 17,735 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $387,058 | 15,155 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $266,268 | 14,917 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $193,355 | 14,052 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||